Clinical trial
A First-in-Human Study of CAN04 in Patients With Solid Malignant Tumors
NCT03267316
Study timeline
Study start (actual)2017-09-19Date precision: day
Registry last updated2024-08-22
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non Small Cell Lung Cancerunresolved
Pancreatic Ductal Adenocarcinomaunresolved
Triple Negative Breast Cancerunresolved
Colorectal Cancerunresolved
Interventions
CAN04BIOLOGICAL
CisplatinDRUG · verified · RxNorm: cisplatin
GemcitabineDRUG · verified · RxNorm: gemcitabine
Nab-paclitaxelDRUG
CarboplatinDRUG · verified · RxNorm: carboplatin
PemetrexedDRUG · verified · RxNorm: pemetrexed
Sponsors & collaborators
Cantargia ABlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03267316 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.